Global Companion Diagnostic Tests in Oncology Market Research Report 2025(Status and Outlook)

March 2025 | 222 pages | ID: GC4C9DBE7B8AEN
Bosson Research

Abstracts

Report Overview

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.

This report provides a deep insight into the global Companion Diagnostic Tests in Oncology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostic Tests in Oncology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostic Tests in Oncology market in any manner.

Global Companion Diagnostic Tests in Oncology Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott

Roche

Genomic Health

QIAGEN

Agilent

Agendia

BioMerieux

Illumina

Siemens Healthcare

Thermo Fisher

Market Segmentation (by Type)

Protein Detection

DNA Detection

Market Segmentation (by Application)

Pharmaceutical & Biotechnology Companies

Medical Device Companies

Research Institutes

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Companion Diagnostic Tests in Oncology Market
• Overview of the regional outlook of the Companion Diagnostic Tests in Oncology Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostic Tests in Oncology Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Companion Diagnostic Tests in Oncology
1.2 Key Market Segments
1.2.1 Companion Diagnostic Tests in Oncology Segment by Type
1.2.2 Companion Diagnostic Tests in Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Companion Diagnostic Tests in Oncology Market Overview
2.1 Global Market Overview
2.1.1 Global Companion Diagnostic Tests in Oncology Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Companion Diagnostic Tests in Oncology Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Companion Diagnostic Tests in Oncology Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Companion Diagnostic Tests in Oncology Product Life Cycle
3.3 Global Companion Diagnostic Tests in Oncology Sales by Manufacturers (2020-2025)
3.4 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Manufacturers (2020-2025)
3.5 Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Companion Diagnostic Tests in Oncology Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Companion Diagnostic Tests in Oncology Manufacturing Sites, Area Served, Product Type
3.8 Companion Diagnostic Tests in Oncology Market Competitive Situation and Trends
3.8.1 Companion Diagnostic Tests in Oncology Market Concentration Rate
3.8.2 Global 5 and 10 Largest Companion Diagnostic Tests in Oncology Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Companion Diagnostic Tests in Oncology Industry Chain Analysis
4.1 Companion Diagnostic Tests in Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Companion Diagnostic Tests in Oncology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Companion Diagnostic Tests in Oncology Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Companion Diagnostic Tests in Oncology Market
5.7 ESG Ratings of Leading Companies
6 Global Companion Diagnostic Tests in Oncology Market by Region
6.1 Global Companion Diagnostic Tests in Oncology Market Size by Region
6.1.1 Global Companion Diagnostic Tests in Oncology Market Size by Region
6.1.2 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Region
6.2 Global Companion Diagnostic Tests in Oncology Sales by Region
6.2.1 Global Companion Diagnostic Tests in Oncology Sales by Region
6.2.2 Global Companion Diagnostic Tests in Oncology Sales Market Share by Region
7 North America Market Overview
7.1 North America Companion Diagnostic Tests in Oncology Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Companion Diagnostic Tests in Oncology Market Size by Type
7.3 North America Companion Diagnostic Tests in Oncology Market Size by Application
8 Europe Market Overview
8.1 Europe Companion Diagnostic Tests in Oncology Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type
8.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Type
9.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Application
10 South America Market Overview
10.1 South America Companion Diagnostic Tests in Oncology Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Companion Diagnostic Tests in Oncology Market Size by Type
10.3 South America Companion Diagnostic Tests in Oncology Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Companion Diagnostic Tests in Oncology Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Companion Diagnostic Tests in Oncology Market Size by Type
11.3 Middle East and Africa Companion Diagnostic Tests in Oncology Market Size by Application
12 Companion Diagnostic Tests in Oncology Market Production by Region
12.1 Global Production of Companion Diagnostic Tests in Oncology by Region(2020-2025)
12.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Region (2020-2025)
12.3 Global Companion Diagnostic Tests in Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Companion Diagnostic Tests in Oncology Production
12.4.1 North America Companion Diagnostic Tests in Oncology Production Growth Rate (2020-2025)
12.4.2 North America Companion Diagnostic Tests in Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Companion Diagnostic Tests in Oncology Production
12.5.1 Europe Companion Diagnostic Tests in Oncology Production Growth Rate (2020-2025)
12.5.2 Europe Companion Diagnostic Tests in Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Companion Diagnostic Tests in Oncology Production (2020-2025)
12.6.1 Japan Companion Diagnostic Tests in Oncology Production Growth Rate (2020-2025)
12.6.2 Japan Companion Diagnostic Tests in Oncology Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Companion Diagnostic Tests in Oncology Production (2020-2025)
12.7.1 China Companion Diagnostic Tests in Oncology Production Growth Rate (2020-2025)
12.7.2 China Companion Diagnostic Tests in Oncology Production, Revenue, Price and Gross Margin (2020-2025)
13 Companion Diagnostic Tests in Oncology Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Companion Diagnostic Tests in Oncology Sales Market Share by Type (2020-2033)
13.3 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2020-2033)
13.4 Global Companion Diagnostic Tests in Oncology Price by Type (2020-2033)
14 Companion Diagnostic Tests in Oncology Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Companion Diagnostic Tests in Oncology Market Sales by Application (2020-2033)
14.3 Global Companion Diagnostic Tests in Oncology Market Size (M USD) by Application (2020-2033)
14.4 Global Companion Diagnostic Tests in Oncology Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Abbott
15.1.1 Abbott Basic Information
15.1.2 Abbott Companion Diagnostic Tests in Oncology Product Overview
15.1.3 Abbott Companion Diagnostic Tests in Oncology Product Market Performance
15.1.4 Abbott Business Overview
15.1.5 Abbott SWOT Analysis
15.1.6 Abbott Recent Developments
15.2 Roche
15.2.1 Roche Basic Information
15.2.2 Roche Companion Diagnostic Tests in Oncology Product Overview
15.2.3 Roche Companion Diagnostic Tests in Oncology Product Market Performance
15.2.4 Roche Business Overview
15.2.5 Roche SWOT Analysis
15.2.6 Roche Recent Developments
15.3 Genomic Health
15.3.1 Genomic Health Basic Information
15.3.2 Genomic Health Companion Diagnostic Tests in Oncology Product Overview
15.3.3 Genomic Health Companion Diagnostic Tests in Oncology Product Market Performance
15.3.4 Genomic Health Business Overview
15.3.5 Genomic Health SWOT Analysis
15.3.6 Genomic Health Recent Developments
15.4 QIAGEN
15.4.1 QIAGEN Basic Information
15.4.2 QIAGEN Companion Diagnostic Tests in Oncology Product Overview
15.4.3 QIAGEN Companion Diagnostic Tests in Oncology Product Market Performance
15.4.4 QIAGEN Business Overview
15.4.5 QIAGEN Recent Developments
15.5 Agilent
15.5.1 Agilent Basic Information
15.5.2 Agilent Companion Diagnostic Tests in Oncology Product Overview
15.5.3 Agilent Companion Diagnostic Tests in Oncology Product Market Performance
15.5.4 Agilent Business Overview
15.5.5 Agilent Recent Developments
15.6 Agendia
15.6.1 Agendia Basic Information
15.6.2 Agendia Companion Diagnostic Tests in Oncology Product Overview
15.6.3 Agendia Companion Diagnostic Tests in Oncology Product Market Performance
15.6.4 Agendia Business Overview
15.6.5 Agendia Recent Developments
15.7 BioMerieux
15.7.1 BioMerieux Basic Information
15.7.2 BioMerieux Companion Diagnostic Tests in Oncology Product Overview
15.7.3 BioMerieux Companion Diagnostic Tests in Oncology Product Market Performance
15.7.4 BioMerieux Business Overview
15.7.5 BioMerieux Recent Developments
15.8 Illumina
15.8.1 Illumina Basic Information
15.8.2 Illumina Companion Diagnostic Tests in Oncology Product Overview
15.8.3 Illumina Companion Diagnostic Tests in Oncology Product Market Performance
15.8.4 Illumina Business Overview
15.8.5 Illumina Recent Developments
15.9 Siemens Healthcare
15.9.1 Siemens Healthcare Basic Information
15.9.2 Siemens Healthcare Companion Diagnostic Tests in Oncology Product Overview
15.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Product Market Performance
15.9.4 Siemens Healthcare Business Overview
15.9.5 Siemens Healthcare Recent Developments
15.10 Thermo Fisher
15.10.1 Thermo Fisher Basic Information
15.10.2 Thermo Fisher Companion Diagnostic Tests in Oncology Product Overview
15.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Product Market Performance
15.10.4 Thermo Fisher Business Overview
15.10.5 Thermo Fisher Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Companion Diagnostic Tests in Oncology Market Size by Type (M USD)
Table 4. Global Companion Diagnostic Tests in Oncology Market Size by Application (M USD)
Table 5. Companion Diagnostic Tests in Oncology Market Size Comparison by Region (M USD)
Table 6. Global Companion Diagnostic Tests in Oncology Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Companion Diagnostic Tests in Oncology Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Companion Diagnostic Tests in Oncology Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Companion Diagnostic Tests in Oncology Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2024)
Table 11. Global Market Companion Diagnostic Tests in Oncology Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Companion Diagnostic Tests in Oncology Manufacturing Sites and Area Served
Table 13. Manufacturers Companion Diagnostic Tests in Oncology Product Type
Table 14. Global Companion Diagnostic Tests in Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostic Tests in Oncology Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Companion Diagnostic Tests in Oncology Market Size Comparison by Region (M USD)
Table 26. Global Companion Diagnostic Tests in Oncology Market Size by Region (2020-2033) & (M USD)
Table 27. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Region (2020-2033)
Table 28. Global Companion Diagnostic Tests in Oncology Sales by Region (2020-2033) & (K Units)
Table 29. Global Companion Diagnostic Tests in Oncology Sales Market Share by Region (2020-2033)
Table 30. North America Companion Diagnostic Tests in Oncology Market Size by Country (2020-2033) & (M USD)
Table 31. North America Companion Diagnostic Tests in Oncology Sales by Country (2020-2033) & (K Units)
Table 32. North America Companion Diagnostic Tests in Oncology Sales by Type (K Units)
Table 33. North America Companion Diagnostic Tests in Oncology Market Size by Type (M USD)
Table 34. North America Companion Diagnostic Tests in Oncology Sales (K Units) by Type (2020-2033)
Table 35. North America Companion Diagnostic Tests in Oncology Market Size (M USD) by Type (2020-2033)
Table 36. North America Companion Diagnostic Tests in Oncology Sales by Application (K Units)
Table 37. North America Companion Diagnostic Tests in Oncology Market Size by Application (M USD)
Table 38. North America Companion Diagnostic Tests in Oncology Sales (K Units) by Application (2020-2033)
Table 39. North America Companion Diagnostic Tests in Oncology Market Size (M USD) by Application (2020-2033)
Table 40. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Companion Diagnostic Tests in Oncology Sales by Country (2020-2033) & (K Units)
Table 42. Europe Companion Diagnostic Tests in Oncology Sales by Type (K Units)
Table 43. Europe Companion Diagnostic Tests in Oncology Market Size by Type (M USD)
Table 44. Europe Companion Diagnostic Tests in Oncology Sales (K Units) by Type (2020-2033)
Table 45. Europe Companion Diagnostic Tests in Oncology Market Size (M USD) by Type (2020-2033)
Table 46. Europe Companion Diagnostic Tests in Oncology Sales by Application (K Units)
Table 47. Europe Companion Diagnostic Tests in Oncology Market Size by Application (M USD)
Table 48. Europe Companion Diagnostic Tests in Oncology Sales (K Units) by Application (2020-2033)
Table 49. Europe Companion Diagnostic Tests in Oncology Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Companion Diagnostic Tests in Oncology Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Companion Diagnostic Tests in Oncology Sales by Type (K Units)
Table 53. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Type (M USD)
Table 54. Asia-Pacific Companion Diagnostic Tests in Oncology Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Companion Diagnostic Tests in Oncology Sales by Application (K Units)
Table 57. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Application (M USD)
Table 58. Asia-Pacific Companion Diagnostic Tests in Oncology Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (M USD) by Application (2020-2025)
Table 60. South America Companion Diagnostic Tests in Oncology Market Size by Country (2020-2033) & (M USD)
Table 61. South America Companion Diagnostic Tests in Oncology Sales by Country (2020-2033) & (K Units)
Table 62. South America Companion Diagnostic Tests in Oncology Sales by Type (K Units)
Table 63. South America Companion Diagnostic Tests in Oncology Market Size by Type (M USD)
Table 64. South America Companion Diagnostic Tests in Oncology Sales (K Units) by Type (2020-2033)
Table 65. South America Companion Diagnostic Tests in Oncology Market Size (M USD) by Type (2020-2033)
Table 66. South America Companion Diagnostic Tests in Oncology Sales by Application (K Units)
Table 67. South America Companion Diagnostic Tests in Oncology Market Size by Application (M USD)
Table 68. South America Companion Diagnostic Tests in Oncology Sales (K Units) by Application (2020-2033)
Table 69. South America Companion Diagnostic Tests in Oncology Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Companion Diagnostic Tests in Oncology Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Companion Diagnostic Tests in Oncology Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Companion Diagnostic Tests in Oncology Sales by Type (K Units)
Table 73. Middle East and Africa Companion Diagnostic Tests in Oncology Market Size by Type (M USD)
Table 74. Middle East and Africa Companion Diagnostic Tests in Oncology Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Companion Diagnostic Tests in Oncology Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Companion Diagnostic Tests in Oncology Sales by Application (K Units)
Table 77. Middle East and Africa Companion Diagnostic Tests in Oncology Market Size by Application (M USD)
Table 78. Middle East and Africa Companion Diagnostic Tests in Oncology Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Companion Diagnostic Tests in Oncology Market Size (M USD) by Application (2020-2033)
Table 80. Global Companion Diagnostic Tests in Oncology Production (K Units) by Region(2020-2025)
Table 81. Global Companion Diagnostic Tests in Oncology Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Region (2020-2025)
Table 83. Global Companion Diagnostic Tests in Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Companion Diagnostic Tests in Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Companion Diagnostic Tests in Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Companion Diagnostic Tests in Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Companion Diagnostic Tests in Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Companion Diagnostic Tests in Oncology Sales by Type (K Units)
Table 89. Global Companion Diagnostic Tests in Oncology Market Size by Type (M USD)
Table 90. Global Companion Diagnostic Tests in Oncology Sales (K Units) by Type (2020-2033)
Table 91. Global Companion Diagnostic Tests in Oncology Sales Market Share by Type (2020-2033)
Table 92. Global Companion Diagnostic Tests in Oncology Market Size (M USD) by Type (2020-2033)
Table 93. Global Companion Diagnostic Tests in Oncology Market Size Share by Type (2020-2033)
Table 94. Global Companion Diagnostic Tests in Oncology Sales (K Units) by Application
Table 95. Global Companion Diagnostic Tests in Oncology Market Size by Application(M USD)
Table 96. Global Companion Diagnostic Tests in Oncology Sales by Application (2020-2033) & (K Units)
Table 97. Global Companion Diagnostic Tests in Oncology Sales Market Share by Application (2020-2033)
Table 98. Global Companion Diagnostic Tests in Oncology Market Size by Application (2020-2033) & (M USD)
Table 99. Global Companion Diagnostic Tests in Oncology Market Share by Application (2020-2033)
Table 100. Global Companion Diagnostic Tests in Oncology Sales Growth Rate by Application (2020-2033)
Table 101. Abbott Basic Information
Table 102. Abbott Companion Diagnostic Tests in Oncology Product Overview
Table 103. Abbott Companion Diagnostic Tests in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Abbott Business Overview
Table 105. Abbott SWOT Analysis
Table 106. Abbott Recent Developments
Table 107. Roche Basic Information
Table 108. Roche Companion Diagnostic Tests in Oncology Product Overview
Table 109. Roche Companion Diagnostic Tests in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Roche Business Overview
Table 111. Roche SWOT Analysis
Table 112. Roche Recent Developments
Table 113. Genomic Health Basic Information
Table 114. Genomic Health Companion Diagnostic Tests in Oncology Product Overview
Table 115. Genomic Health Companion Diagnostic Tests in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Genomic Health Business Overview
Table 117. Genomic Health SWOT Analysis
Table 118. Genomic Health Recent Developments
Table 119. QIAGEN Basic Information
Table 120. QIAGEN Companion Diagnostic Tests in Oncology Product Overview
Table 121. QIAGEN Companion Diagnostic Tests in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. QIAGEN Business Overview
Table 123. QIAGEN Recent Developments
Table 124. Agilent Basic Information
Table 125. Agilent Companion Diagnostic Tests in Oncology Product Overview
Table 126. Agilent Companion Diagnostic Tests in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Agilent Business Overview
Table 128. Agilent Recent Developments
Table 129. Agendia Basic Information
Table 130. Agendia Companion Diagnostic Tests in Oncology Product Overview
Table 131. Agendia Companion Diagnostic Tests in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Agendia Business Overview
Table 133. Agendia Recent Developments
Table 134. BioMerieux Basic Information
Table 135. BioMerieux Companion Diagnostic Tests in Oncology Product Overview
Table 136. BioMerieux Companion Diagnostic Tests in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. BioMerieux Business Overview
Table 138. BioMerieux Recent Developments
Table 139. Illumina Basic Information
Table 140. Illumina Companion Diagnostic Tests in Oncology Product Overview
Table 141. Illumina Companion Diagnostic Tests in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Illumina Business Overview
Table 143. Illumina Recent Developments
Table 144. Siemens Healthcare Basic Information
Table 145. Siemens Healthcare Companion Diagnostic Tests in Oncology Product Overview
Table 146. Siemens Healthcare Companion Diagnostic Tests in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Siemens Healthcare Business Overview
Table 148. Siemens Healthcare Recent Developments
Table 149. Thermo Fisher Basic Information
Table 150. Thermo Fisher Companion Diagnostic Tests in Oncology Product Overview
Table 151. Thermo Fisher Companion Diagnostic Tests in Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Thermo Fisher Business Overview
Table 153. Thermo Fisher Recent Developments
List of Figures
Figure 1. Product Picture of Companion Diagnostic Tests in Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostic Tests in Oncology Market Size (M USD), 2024-2033
Figure 5. Global Companion Diagnostic Tests in Oncology Market Size (M USD) (2020-2033)
Figure 6. Global Companion Diagnostic Tests in Oncology Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostic Tests in Oncology Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Companion Diagnostic Tests in Oncology Product Life Cycle
Figure 13. Companion Diagnostic Tests in Oncology Sales Share by Manufacturers in 2024
Figure 14. Global Companion Diagnostic Tests in Oncology Revenue Share by Manufacturers in 2024
Figure 15. Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Companion Diagnostic Tests in Oncology Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostic Tests in Oncology Revenue in 2024
Figure 18. Industry Chain Map of Companion Diagnostic Tests in Oncology
Figure 19. Global Companion Diagnostic Tests in Oncology Market PEST Analysis
Figure 20. Global Companion Diagnostic Tests in Oncology Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Companion Diagnostic Tests in Oncology Market Size by Region
Figure 27. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Region (2020-2033)
Figure 28. Global Companion Diagnostic Tests in Oncology Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Companion Diagnostic Tests in Oncology Market Size (M USD) by Country
Figure 33. USA Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Companion Diagnostic Tests in Oncology Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Companion Diagnostic Tests in Oncology Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Companion Diagnostic Tests in Oncology Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Companion Diagnostic Tests in Oncology Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Companion Diagnostic Tests in Oncology Market Size (M USD)by Type
Figure 40. North America Companion Diagnostic Tests in Oncology Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Companion Diagnostic Tests in Oncology Market Size (M USD) by Country
Figure 45. Germany Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Companion Diagnostic Tests in Oncology Market Size (M USD) by Type
Figure 56. Europe Companion Diagnostic Tests in Oncology Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (M USD) by Country
Figure 61. China Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (M USD) by Type
Figure 72. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Companion Diagnostic Tests in Oncology Market Size (M USD) by Country
Figure 77. Brazil Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Companion Diagnostic Tests in Oncology Market Size (M USD) by Type
Figure 84. South America Companion Diagnostic Tests in Oncology Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Companion Diagnostic Tests in Oncology Market Size (M USD) by Country
Figure 89. Saudi Arabia Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Companion Diagnostic Tests in Oncology Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Companion Diagnostic Tests in Oncology Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Companion Diagnostic Tests in Oncology Market Size (M USD) by Type
Figure 100. Middle East and Africa Companion Diagnostic Tests in Oncology Market Size (M USD) by Application
Figure 101. Global Companion Diagnostic Tests in Oncology Production Market Share by Region (2020-2025)
Figure 102. North America Companion Diagnostic Tests in Oncology Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Companion Diagnostic Tests in Oncology Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Companion Diagnostic Tests in Oncology Production (K Units) Growth Rate (2020-2025)
Figure 105. China Companion Diagnostic Tests in Oncology Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Companion Diagnostic Tests in Oncology Market Size by Type (M USD)
Figure 108. Sales Market Share of Companion Diagnostic Tests in Oncology by Type (2020-2033)
Figure 109. Sales Market Share of Companion Diagnostic Tests in Oncology by Type in 2024
Figure 110. Market Size Share of Companion Diagnostic Tests in Oncology by Type (2020-2033)
Figure 111. Market Size Share of Companion Diagnostic Tests in Oncology by Type in 2024
Figure 112. Global Companion Diagnostic Tests in Oncology Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Companion Diagnostic Tests in Oncology Market Size by Application(M USD)
Figure 115. Global Companion Diagnostic Tests in Oncology Market Share by Application
Figure 116. Global Companion Diagnostic Tests in Oncology Sales Market Share by Application (2020-2033)
Figure 117. Global Companion Diagnostic Tests in Oncology Sales Market Share by Application in 2024
Figure 118. Global Companion Diagnostic Tests in Oncology Market Share by Application (2020-2033)
Figure 119. Global Companion Diagnostic Tests in Oncology Market Share by Application in 2024
Figure 120. Global Companion Diagnostic Tests in Oncology Sales Growth Rate by Application (2020-2033)